Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk

Genes carrying high-penetrance germline mutations may also be associated with cancer susceptibility through common low-penetrance genetic variants. To increase the knowledge on genetic pancreatic ductal adenocarcinoma (PDAC) aetiology, the common genetic variability of PDAC familial genes was analys...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Giaccherini Matteo
Farinella Riccardo
Gentiluomo Manuel
Mohelnikova-Duchonova Beatrice
Kauffmann Emanuele Federico
Palmeri Matteo
Uzunoglu Faik
Soucek Pavel
Petrauskas Dalius
Cavestro Giulia Martina
Szentesi Andrea Ildikó
Hussein Tamás
Hegyi Péter
Bunduc Stefania
Petrányi Ágota Eszter
et al
Dokumentumtípus: Cikk
Megjelent: 2023
Sorozat:INTERNATIONAL JOURNAL OF CANCER 153 No. 2
Tárgyszavak:
doi:10.1002/ijc.34383

mtmt:33291604
Online Access:http://publicatio.bibl.u-szeged.hu/27184
LEADER 02744nab a2200397 i 4500
001 publ27184
005 20230516084335.0
008 230516s2023 hu o 0|| Angol d
022 |a 0020-7136 
024 7 |a 10.1002/ijc.34383  |2 doi 
024 7 |a 33291604  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Angol 
100 1 |a Giaccherini Matteo 
245 1 0 |a Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk  |h [elektronikus dokumentum] /  |c  Giaccherini Matteo 
260 |c 2023 
300 |a 373-379 
490 0 |a INTERNATIONAL JOURNAL OF CANCER  |v 153 No. 2 
520 3 |a Genes carrying high-penetrance germline mutations may also be associated with cancer susceptibility through common low-penetrance genetic variants. To increase the knowledge on genetic pancreatic ductal adenocarcinoma (PDAC) aetiology, the common genetic variability of PDAC familial genes was analysed in this study. We conducted a multi-phase study analysing 7,745 single nucleotide polymorphisms (SNPs) from 29 genes reported to harbour a high-penetrance PDAC-associated mutation in at least one published study. To assess the effect of the SNPs on PDAC risk, a total of 14,666 PDAC cases and 221,897 controls across five different studies were analysed. The T allele of the rs1412832 polymorphism, that is situated in the CDKN2B-AS1/ANRIL, showed a genome-wide significant association with increased risk of developing PDAC (OR=1.11, 95%CI=1.07-1.15, P=5.25×10-9 ). CDKN2B-AS1/ANRIL is a long non-coding RNA, situated in 9p21.3, and regulates many target genes, among which CDKN2A (p16) that frequently shows deleterious somatic and germline mutations and deregulation in PDAC. Our results strongly support the role of the genetic variability of the 9p21.3 region in PDAC aetiopathogenesis and highlight the importance of secondary analysis as a tool for discovering new risk loci in complex human diseases. This article is protected by copyright. All rights reserved. 
650 4 |a Klinikai orvostan 
700 0 1 |a Farinella Riccardo  |e aut 
700 0 1 |a Gentiluomo Manuel  |e aut 
700 0 2 |a Mohelnikova-Duchonova Beatrice  |e aut 
700 0 2 |a Kauffmann Emanuele Federico  |e aut 
700 0 2 |a Palmeri Matteo  |e aut 
700 0 2 |a Uzunoglu Faik  |e aut 
700 0 2 |a Soucek Pavel  |e aut 
700 0 2 |a Petrauskas Dalius  |e aut 
700 0 2 |a Cavestro Giulia Martina  |e aut 
700 0 2 |a Szentesi Andrea Ildikó  |e aut 
700 0 2 |a Hussein Tamás  |e aut 
700 0 2 |a Hegyi Péter  |e aut 
700 0 2 |a Bunduc Stefania  |e aut 
700 0 2 |a Petrányi Ágota Eszter  |e aut 
700 0 2 |a et al.  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/27184/1/IntlJournalofCancer-2022-Giaccherini.pdf  |z Dokumentum-elérés